Announcements 
International Conference On Recombinant DNA 
A conference is to be held at Wye Agricultural Col¬ 
lege, United Kingdom from April 1 to 4 which will 
be sponsored by the Royal Society and COGENE 
(see page ). The purpose of the conference is to 
review the current status of recombinant DNA 
research and technology and discuss issues of 
research support, regulation, and practical appli¬ 
cations. The meeting will be divided into the fol¬ 
lowing sections: 
1. Recombinant DNA techniques put into biolog¬ 
ical perspective 
2. Achievements of recombinant DNA research 
3. Practical benefits of recombinant DNA 
research 
4. Re-examination of basic assumptions 
The proceedings of this meeting are to be pub¬ 
lished by Pergamon Press (edited by Dr. Joan 
Morgan and Dr. W.J. Whelan) by approximately 
August, 1979. 
Laboratory Safety Training Short Courses 
Laboratory safety training short courses for 
1979 are set as conducted by the University of 
Minnesota School of Public Health under contract 
from the National Cancer Institute Office of 
Research Safety. 
Courses on "Biohazard Containment and Con¬ 
trol for Recombinant DNA Molecules" will be pres¬ 
ented May 30-31, University of California at Los 
Angeles: June 12-13, University of Wisconsin, 
Madison and June 26-27, National Institutes of 
Health, Bethesda, MD. These courses are 
directed at principal investigators, scientists, and 
senior technicians working with genetic recombi¬ 
nants. Lectures and workshops will emphasize 
interpretation of the N.I.H. Guidelines for Recom¬ 
binant DNA Research. 
Two courses on "Biohazard and Injury Control 
in the Biomedical Laboratory” will be held. They 
are set for September 11-13, Ohio State Univer¬ 
sity, Columbus, and December 11-13, National 
Institutes of Health, Bethesda. Emphasis at these 
courses is placed on biohazards and technicians 
working in fields related to cancer virology. 
Support from the National Cancer Institute ena¬ 
bles the University of Minnesota to offer both 
courses tuition free. Participants pay only for travel 
and living expenses. Enrollment is limited and 
early application is recommended. 
Information on the courses can be obtained 
from Donald Vesley, Ph.D., Professor, School of 
Public Health, 11 58 Mayo Memorial Building, 420 
Delaware St. S.E., University of Minnesota, Min¬ 
neapolis, MN 55455. Telephone (612) 373-5943. 
Future Meetings of the NIH Recombinant DNA Advisory Committee 
May 21-23, 1979 
September 5-7, 1979 
December 5-7, 1979 
31 
